by In2Pharma | May 22, 2025 | News
Belgium In 2023, a new royal decree (19 January 2023) was issued by the Belgian government allowing the export (every shipment to another country) of medicines to be temporarily restricted. The importance of complying with the decree has been made very clear as this...
by In2Pharma | May 22, 2025 | News
Belgium The FAMHP launched a new version of Narcoreg, the mandatory online application for the registration of deliveries and receipts of narcotics and psychotropic substances, on 21 May 2025. The new version was developed based on valuable feedback from the industry...
by In2Pharma | Jan 8, 2025 | News
Belgium Companies with a GDP-certificate with validity date end December 2024, should have received – addressed to their RP – a communication from the FAMHP with regard to the GDP-certificate expiring in December 2024. In parallel, the below...
by In2Pharma | Oct 27, 2023 | News
Belgium On 16 October, the Belgian federal agency for medicines and health products (FAMHP) has introduced a new application for the effective management of marketing authorisation and vigilance dossiers. Data Tracking System (DTS) will replace 4 MeSeA applications:...
by In2Pharma | Sep 29, 2023 | News
Belgium The Belgian “National Medicines Verification System” (NMVS) is linked to the “European Alert Management System” (EAMS) via a “National Alert Management System” (NAMS) since 1 July 2023. Since there is now the possibility of...
